Related Experiment Video
Updated: Jul 26, 2026
Application and Methodology of the Non-destructive 19F Time-domain NMR Technique to Measure the Content in Fluorine-containing Drug Products
Published on: August 22, 2017
[Impurity analysis and their structure determination of gatifloxacin]
Hong-hua Zhou1, Song-mei Gao, Er-hua Wang
1Center for Instrumental Analysis, China Pharmaceutical University, Nanjing 210009, China. Honghua.zhou@sohu.com
Aim:
To analyse the impurities of gatifloxacin.
Methods:
The impurity of gatifloxacin were analysized and determinated by RP-HPLC/electrospray ionization mass spectrometry with a Zorbax SB-C18(4.6 mm x 150 mm ID, 5 microns). The mobile phase was 3% acetic acid/acetonitrile-3% acetic acid/water (15:85). The two compounds were synthesized: 1-cyclopropyl-6-fluoro-1, 4-dihydro-8-methoxy-7-(1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid (DMP) and 1-cyclopropyl-6-fluoro-1, 4-dihydro-8-hydro-7-(3-methy-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid (DMO). Their liquid chromatogram, UV, MS were compared with those of the impurity of gatifloxacin.
Results:
The mass of the impurity was 14 less than that of gatifloxacin. It means the impurity was CH2 less than gatifloxacin. The tR (HPLC), UV and MS of DMP were the same as those of the impurity of gatifloxacin.
Conclusion:
Based on the tR (HPLC), UV and MS, the impurity of gatifloxacin is confirmed as DMP.
